Atlas Trials

Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Clinical trial NCT02090283 · TERMINATED

Trial details

NCT number
NCT02090283
Sponsor
Scioderm, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Epidermolysis Bullosa
Start date
2014-03-26
Primary completion
2018-09-14
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.